Biodelivery sciences international, inc. (BDSI)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Assets
Current assets:
Cash and cash equivalents

70,613

63,888

55,863

57,215

41,329

43,822

49,482

55,724

12,090

21,195

19,746

27,508

35,219

32,019

44,682

57,464

69,393

83,560

54,429

67,655

63,459

70,472

85,793

78,364

88,199

23,176

38,296

37,430

49,666

63,189

31,319

43,030

32,114

10,750

15,119

21,188

18,208

Accounts receivable, net

45,114

38,790

33,422

24,879

16,008

13,627

12,568

9,410

8,123

8,852

10,791

7,753

7,102

2,967

3,089

2,408

2,132

2,488

1,406

1,526

3,031

3,141

205

12,639

2,531

2,794

885

509

227

520

24

23

197

101

1,654

222

633

Inventory, net

15,003

11,312

10,766

9,974

7,259

5,406

5,434

6,168

5,441

6,091

6,466

6,564

8,145

3,368

4,018

4,426

4,821

2,558

1,887

1,533

2,550

1,828

2,023

795

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

2,600

3,769

4,874

3,298

2,970

3,188

4,155

2,156

2,828

3,610

2,310

2,657

3,942

4,136

4,470

3,612

3,815

3,933

3,609

2,749

2,704

2,568

1,435

600

703

631

454

269

502

226

227

129

574

229

249

842

236

Total current assets

133,330

117,759

104,925

95,366

67,566

66,043

71,639

73,458

28,482

39,748

39,313

44,482

54,408

42,490

56,259

67,910

80,161

92,539

61,331

73,463

71,744

78,009

89,458

92,400

91,434

26,601

39,636

38,209

50,396

63,936

31,570

43,182

32,887

11,081

17,023

22,253

19,077

Property and equipment, net

1,995

2,075

3,713

3,853

3,952

3,072

3,170

3,366

3,621

3,778

4,202

4,437

4,549

4,230

4,253

4,299

4,412

4,262

4,261

4,305

3,948

3,890

1,464

237

235

3,023

174

2,649

2,724

2,835

2,944

3,057

3,174

3,288

3,370

3,344

3,424

Idle equipment, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,738

3,462

3,301

-

2,469

-

-

-

-

-

-

-

-

-

-

Goodwill

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

2,715

License and distribution rights, net

58,576

60,309

62,044

63,778

34,875

36,000

37,125

38,250

39,375

40,500

41,625

42,750

45,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Licenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,900

1,900

1,900

-

1,900

1,900

1,900

1,900

1,900

1,900

1,900

1,900

1,900

1,900

1,900

Acquired product rights

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9,050

9,050

9,050

-

9,050

9,050

9,050

9,050

9,050

9,050

9,050

8,000

-

-

-

Acquired product rights

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,000

8,000

8,000

Accumulated amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,481

6,238

5,996

-

5,510

5,268

5,025

4,770

4,515

4,260

4,004

3,749

3,526

3,304

2,858

Other intangible assets, net

0

47

211

375

539

703

867

1,032

1,196

1,360

1,558

1,800

918

2,285

2,528

2,771

3,013

3,256

3,498

3,741

3,984

4,226

4,468

4,711

4,953

5,196

5,439

5,681

5,924

6,179

6,434

6,689

6,945

6,150

6,373

6,595

7,041

Derivative asset, warrant

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

28

50

187

401

661

388

466

590

1,299

Other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

610

684

78

-

235

313

392

470

131

-

-

21

21

21

21

21

21

21

21

Total assets

196,616

182,905

173,608

166,087

109,647

108,533

115,516

118,821

75,389

88,101

89,413

96,184

107,590

51,720

65,755

77,695

90,301

102,772

72,415

84,908

82,469

88,840

101,080

103,841

103,031

38,005

50,565

49,255

61,788

75,738

43,874

56,068

46,406

23,645

29,969

35,521

33,580

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued liabilities

60,931

53,993

46,545

40,762

23,484

21,539

23,919

23,228

20,335

26,149

30,807

30,613

30,521

17,572

18,839

19,059

19,063

19,501

14,973

12,263

14,512

14,429

13,076

9,496

8,844

10,416

11,070

11,961

9,540

10,755

7,389

5,813

5,002

5,090

-

-

4,656

Notes payable, current maturities, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,446

7,533

9,707

6,707

4,000

1,000

8,000

8,000

8,000

7,333

7,333

7,333

5,333

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued liabilities, other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,034

5,402

-

Deferred revenue, current

-

-

-

-

-

-

-

-

-

-

-

-

-

1,716

1,922

1,965

1,640

1,875

7,236

7,247

7,075

6,772

842

1,302

1,924

2,927

4,074

5,613

7,232

7,990

22,719

22,314

18,672

12,507

12,501

12,523

12,491

Derivative liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

100

114

-

-

-

-

-

-

12,579

10,761

7,470

4,315

3,948

3,030

3,451

4,497

8,949

5,638

2,419

279

788

3,385

4,989

Total current liabilities

60,931

53,993

46,545

40,762

23,484

21,539

23,919

23,228

20,335

26,149

30,807

30,613

30,521

19,288

32,307

28,671

30,410

28,083

26,209

20,510

29,587

29,201

34,498

28,894

25,572

24,991

24,426

20,605

20,224

23,243

39,058

33,765

26,095

17,877

20,324

21,310

22,138

Notes payable, net

58,634

58,568

58,515

58,448

52,286

51,652

50,516

49,394

48,285

47,660

35,701

35,251

34,800

29,272

17,726

21,540

19,267

22,168

25,679

28,653

2,256

3,702

6,091

8,009

9,926

11,845

13,762

-

-

-

-

-

-

-

-

-

-

Deferred revenue, long-term

-

-

-

-

-

-

-

-

-

-

-

-

-

20,000

20,000

20,000

20,000

20,000

-

-

45

841

5,647

4,440

2,217

1,281

1,330

1,563

1,853

2,718

4,257

6,538

8,977

1,647

1,661

1,660

1,655

Other long-term liabilities

463

580

654

727

6,355

5,600

5,511

5,462

5,415

5,415

4,050

4,050

4,050

825

825

825

825

825

825

825

734

700

700

700

700

700

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

120,028

113,141

105,714

99,937

82,125

78,791

79,946

78,084

74,035

79,224

70,558

69,914

69,371

69,385

70,858

71,036

70,502

71,076

52,713

49,988

32,622

34,444

46,937

42,044

38,417

38,817

39,519

22,169

22,078

25,961

43,316

40,303

35,073

19,524

21,985

22,971

23,793

Commitments and contingencies (Note 11)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders' equity:
Preferred Stock, 5,000,000 shares authorized; Series A Non-Voting Convertible Preferred Stock. $0.001 par value, 0 and 2,093,155 shares outstanding at March 31, 2020 and December 31, 2019, respectively; Series B Non-Voting Convertible Preferred Stock, $0.001 par value, 443 and 618 shares outstanding at March 31, 2020 and December 31, 2019, respectively.

0

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

2

3

2

2

2

2

0

0

0

0

-

-

0

Common Stock, $0.001 par value; 175,000,000 shares authorized at March 31, 2020 and December 31, 2019, respectively; 99,821,408 and 96,189,074 shares issued; 99,805,917 and 96,173,583 shares outstanding at March 31, 2020 and December 31, 2019, respectively.

99

96

90

88

74

71

71

59

59

56

56

55

55

54

54

54

54

53

53

53

53

52

50

49

48

39

38

38

38

37

30

29

29

29

29

29

24

Additional paid-in capital

438,163

436,306

433,746

432,358

382,614

381,004

379,824

366,123

316,970

313,922

307,690

303,155

300,225

292,667

289,287

285,072

281,726

274,891

273,069

267,847

263,563

259,920

242,022

224,421

220,567

150,506

149,596

147,149

146,359

143,703

103,091

100,819

100,171

99,709

99,489

98,931

82,055

Treasury stock, at cost,15,491 shares, as of March 31, 2020 and December 31, 2019.

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

47

Accumulated deficit

-361,627

-366,593

-365,897

-366,251

-355,121

-351,288

-344,280

-325,400

-315,630

-305,056

-288,846

-276,895

-262,016

-310,341

-294,399

-278,422

-261,936

-243,203

-253,375

-232,935

-213,724

-205,531

-187,885

-162,628

-155,957

-151,313

-138,543

-120,057

-106,642

-93,919

-102,515

-85,038

-88,820

-95,571

-91,487

-86,364

-72,246

Total stockholders' equity

76,588

69,764

67,894

66,150

27,522

29,700

35,570

40,737

1,354

8,877

18,855

26,270

38,219

-17,665

-5,103

6,659

19,799

31,696

19,702

34,920

49,847

54,396

54,143

61,796

64,614

-812

11,046

27,086

39,710

49,777

558

15,764

11,332

4,120

7,984

12,549

9,786

Total liabilities and stockholders' equity

196,616

182,905

173,608

166,087

109,647

108,533

115,516

118,821

75,389

88,101

89,413

96,184

107,590

51,720

65,755

77,695

90,301

102,772

72,415

84,908

82,469

88,840

101,080

103,841

103,031

38,005

50,565

49,255

61,788

75,738

43,874

56,068

46,406

23,645

29,969

35,521

33,580

Preferred Stock, par value (in usd per share)

0.00

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred Stock, shares authorized (in shares)

5,000

5,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common Stock, par value (in usd per share)

0.00

0.00

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common Stock, shares authorized (in shares)

175,000

175,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common Stock, shares issued (in shares)

99,821

96,189

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common Stock, shares outstanding (in shares)

99,805

96,173

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Treasury stock, shares (in shares)

15

15

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-